Video Experimental Relacionado
Updated: Jul 8, 2026
06:27
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Las interacciones beta de zinc-amiloide en una escala de tiempo de milisegundos estabilizan las especies no
Dror Noy1, Inna Solomonov, Ory Sinkevich
1Structural Biology Department and Electron Microscopy Unit, Weizmann Institute of Science, Rehovot 76100, Israel.
Journal of the American Chemical Society
|January 9, 2008
Resumen
Los pulsos de zinc, no los niveles sostenidos, pueden impulsar la patología de la enfermedad de Alzheimer (EA) al estabilizar los agregados nocivos de beta amiloide. Esta investigación revela el papel del zinc en la patogénesis de la enfermedad de Alzheimer.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- La bioquímica es la bioquímica.
- Patología Patología Patología.
Sus antecedentes:
- El papel del zinc en la patología de la enfermedad de Alzheimer (EA) no está claro.
- Si bien algunas pruebas sugieren que el zinc promueve la deposición de amiloide-beta (Abeta), los bajos niveles de zinc extracelular desafían esto.
- Se conocen altas concentraciones locales transitorias de zinc durante la actividad sináptica, pero su papel en la agregación de Abeta no está establecido.
Objetivo del estudio:
- Para investigar el efecto de los pulsos transitorios de zinc en la agregación de Abeta.
- Para determinar si la exposición corta y alta concentración de zinc promueve formas patógenas de Abeta.
Principales métodos:
- Se utilizaron técnicas estructurales y espectroscópicas con resolución temporal.
- Se introdujo el zinc en pulsos de milisegundos de concentraciones micromolares a Abeta 1-40 in vitro.
Principales resultados:
- Los pulsos de zinc interactúan rápidamente con Abeta 1-40, promoviendo la agregación.
- El zinc estabiliza los agregados de Abeta no fibrilares y patógenos.
- El zinc previene la formación de fibrillas de Abeta menos dañinas al interferir con el autoensamblaje.
Conclusiones:
- Los pulsos transitorios de zinc juegan un papel importante en la patología de Abeta.
- El zinc actúa como un patógeno molecular, estabilizando las formas amiloides no fibrilares dañinas sobre las fibrillas benignas.
Videos de Conceptos Relacionados
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...